New immune therapy aims to train body to clear HPV
NCT ID NCT06959563
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests a biological product mix designed to train the immune system to recognize and clear multiple strains of HPV. The study involves 20 participants with cervical HPV infection who do not have symptoms or signs of cancer. The treatment is given through the skin over 21 days, and researchers will check if the virus is cleared and if the immune system shows a targeted response.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medicine Invention Design, Inc.
Rockville, Maryland, 20853, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily supplement help the body fight off HPV?
- At-Home HPV tests could save lives of women with HIV
- Could a tiny HPV shot still protect? small study tests lower dose
- New Self-Sampling and digital colposcopy could speed up cervical cancer detection
- Could a smaller HPV vaccine dose still protect adults?
- Could a vaginal suppository clear High-Risk HPV?